SGA
IPXL

Sector Gamma AS’s Impax Laboratories, Inc. IPXL Stock Holding History

Sector Gamma AS’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-422,261
Closed -$8.57M – 38
2017
Q3 		$8.57M Sell
422,261
-167,050
-28% -$3.19M 1.31% 22
2017
Q2 		$9.49M Buy
589,311
+55,000
+10% +$812K 1.38% 24
2017
Q1 		$6.76M Buy
534,311
+35,158
+7% +$425K 1.08% 22
2016
Q4 		$6.61M Buy
499,153
+89,189
+22% +$1.52M 1.24% 24
2016
Q3 		$7.32M Buy
409,964
+176,030
+75% +$4.73M 1.28% 24
2016
Q2 		$6.74M Buy
+233,934
New +$7.62M 1.28% 24

Other funds holding IPXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TG
TCW Group Los Angeles, California $13.3B AUM 34.44% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Sector Gamma AS's IPXL Position: Q4 2017 in Review

Sector Gamma AS sold out of Impax Laboratories, Inc. (IPXL) in Q4 2017, closing a stake of 422,261 shares — an estimated $8.57M sold.

Sector Gamma AS first reported a position in IPXL in Q2 2016 and held it in 6 quarters. The position peaked at $9.49M in Q2 2017. 200 funds tracked by Wall St. Rank hold IPXL as of Q4 2017.

  • Sector Gamma AS reported no remaining Impax Laboratories, Inc. position as of Q4 2017 after selling out during the quarter.
  • Sector Gamma AS sold 422,261 Impax Laboratories, Inc. shares in Q4 2017, an estimated $8.57M.
  • Sector Gamma AS first reported a position in Impax Laboratories, Inc. in Q2 2016 and held it in 6 quarters.
  • Sector Gamma AS's Impax Laboratories, Inc. position peaked at $9.49M in Q2 2017.
  • 200 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q4 2017.

Based on Sector Gamma AS's 13F filing for Q4 2017, filed 12 Feb 2018.